Li Watsek
Stock Analyst at Cantor Fitzgerald
(0)
# 4775
Out of 5,270 analysts
89
Total ratings
32.93%
Success rate
-22.36%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Ascendis Pharma | Maintains: Overweight | 170 200 | 154.62 | 29.35% | 17 | Feb 25, 2025 | |
Arvinas | Reiterates: Overweight | n/a | n/a | n/a | 5 | Feb 7, 2025 | |
Acrivon Therapeutics | Initiates Coverage On: Overweight | n/a | n/a | n/a | 1 | Jan 31, 2025 | |
ALX Oncology Holding... | Reiterates: Overweight | n/a | n/a | n/a | 7 | Jan 24, 2025 | |
IDEAYA Biosciences | Reiterates: Overweight | n/a | n/a | n/a | 2 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 10 | Dec 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 7 | Nov 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 4 | Oct 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 20 20 | 5.26 | 280.23% | 2 | Sep 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 5 | Sep 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 1 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 5 | Apr 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 5 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 3 | 1.16 | 158.62% | 4 | Nov 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 220 | 4.14 | 5214.01% | 3 | Sep 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 26 | n/a | n/a | 3 | Sep 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 5 | 1.01 | 395.05% | 3 | Sep 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 1140 | 2.97 | 38283.84% | 2 | Sep 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 60 38 | 1.66 | 2189.16% | 1 | Aug 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 75 69 | n/a | n/a | 2 | Aug 9, 2022 |